cuprizone has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Jin, X; Li, Y; Liu, S; Mi, G; Yang, H; Yang, Z; Ye, E | 1 |
| Avcı, B; Bilge, SS; Bozkurt, A; Günaydın, C; Önger, ME; Terzi, M | 1 |
2 other study(ies) available for cuprizone and piperidines
| Article | Year |
|---|---|
Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.
Topics: Animals; Astrocytes; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cuprizone; Cyclin-Dependent Kinases; Demyelinating Diseases; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Male; Memory Disorders; Memory, Short-Term; Mice, Inbred C57BL; Microglia; Myelin Sheath; Oligodendroglia; Piperidines; Protein Kinase Inhibitors; Stem Cells; Up-Regulation | 2016 |
Tofacitinib enhances remyelination and improves myelin integrity in cuprizone-induced mice.
Topics: Animals; Chelating Agents; Cuprizone; Dose-Response Relationship, Drug; Female; Inflammation Mediators; Janus Kinase Inhibitors; Mice; Mice, Inbred C57BL; Muscle Strength; Myelin Sheath; Piperidines; Pyrimidines; Remyelination | 2021 |